Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Corticosteroid-binding globulin deficiency is a genetic disorder characterized by extreme tiredness (fatigue), particularly after physical exertion, and low blood pressure (hypotension). Corticosteroid-binding globulin (CBG) is a protein primarily produced in the liver that attaches to cortisol, a hormone with numerous functions, including maintaining blood sugar levels, protecting the body from stress, and suppressing inflammation.When cortisol is needed in the body, CBG delivers the cortisol where it is needed and releases it. Signs and symptoms of CBG deficiency vary. While some individuals may experience no symptoms, others are found to have a fatty liver and chronic pain. Some people with CBG deficiency also have chronic fatigue syndrome. CGB deficiency is caused by mutations in the SERPINA6 gene. The SERPINA6 gene is commonly also referred to as the CBG gene. Both autosomal dominant and autosomal recessive inheritance have been reported.While there is still no cure, treatment options will depend on the type and severity of symptoms present and may involve several specialists.
Features include always present findings: Reduced circulating cortisol-binding globulin concentration, Decreased urinary potassium, Decreased circulating cortisol level, and Low red blood cell count (anemia) and others. 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 2 | Reduced circulating cortisol-binding globulin concentration, Decreased circulating cortisol level |
SERPINA6 function has not been fully characterized.
Corticosteroid-binding globulin deficiency is associated with mutations in the SERPINA6 gene on chromosome 14.
Genetic testing for SERPINA6 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 7 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for corticosteroid-binding globulin deficiency.
5 publications have been identified in PubMed for corticosteroid-binding globulin deficiency. Research spans Review / Meta-Analysis (40%), Case Report / Case Series (20%), and Basic Science / Preclinical (20%).
Lee JH (2026). [PMID: 41994485](https://pubmed.ncbi.nlm.nih.gov/41994485/). *J Endocr Soc*. [Epidemiology / Natural History]
Dermitzakis I (2025). [PMID: 40409475](https://pubmed.ncbi.nlm.nih.gov/40409475/). *Infect Genet Evol*. [Review / Meta-Analysis]
Boyle LD (2025). [PMID: 39788946](https://pubmed.ncbi.nlm.nih.gov/39788946/). *Nat Commun*. [Basic Science / Preclinical]
Jiang MR (2025). [PMID: 40365551](https://pubmed.ncbi.nlm.nih.gov/40365551/). *JCEM Case Rep*. [Case Report / Case Series]
Lee JH (2024). [PMID: 38941154](https://pubmed.ncbi.nlm.nih.gov/38941154/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 10:18 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles |
1 |
Increased muscle fatiguability |
Brain and nerves | 1 | Fatigue |
Kidneys and urinary system | 1 | Decreased urinary potassium |
Lab test results | 1 | Decreased circulating cortisol level |
Blood and immune system | 1 | Low red blood cell count (anemia) |
Heart and blood vessels | 1 | Hypertension |